Manager × security

EDMOND DE ROTHSCHILD HOLDING S.A. CVS holdings history

Who else holds this security? →

CVS HEALTH CORP · CUSIP 126650100 · CIK 1649647

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, EDMOND DE ROTHSCHILD HOLDING S.A. reported 288.69K CVS (shares), valued at $29.86M, or 0.39% of its reported non-derivative portfolio. Filed 2026-08-10.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
0.39%
Shares
288.69K
288,689
Reported value
$29.86M
USD

Shares decreased 13.83%; reported value increased 24.12%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20260.39%288,689SEC filing ↗Filed Aug 10, 2026
Q1 20260.35%335,010SEC filing ↗Filed May 13, 2026
Q4 20250.36%315,010SEC filing ↗Filed Feb 17, 2026
Q3 20250.45%383,446SEC filing ↗Filed Nov 13, 2025
Q2 20250.35%313,660SEC filing ↗Filed Aug 12, 2025
Q1 20250.78%653,100SEC filing ↗Filed May 15, 2025
Q4 20240.87%1,132,024SEC filing ↗Filed Feb 12, 2025
Q3 20241.18%1,169,683SEC filing ↗Filed Nov 14, 2024
Q2 20241.13%1,121,507SEC filing ↗Filed Aug 13, 2024
Q1 20241.51%1,131,873SEC filing ↗Filed May 8, 2024
Q4 20231.85%1,302,620SEC filing ↗Filed Feb 12, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20231.85%1,302,620$102.85MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 12, 2024
Q1 20241.51%1,131,873$90.28MShares decreased 13.11%; reported value decreased 12.23%, and weight changed -0.34 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 8, 2024
Q2 20241.13%1,121,507$66.24MShares decreased 0.92%; reported value decreased 26.63%, and weight changed -0.38 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2024
Q3 20241.18%1,169,683$73.55MShares increased 4.30%; reported value increased 11.04%, and weight changed +0.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20240.87%1,132,024$50.82MShares decreased 3.22%; reported value decreased 30.91%, and weight changed -0.31 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2025
Q1 20250.78%653,100$44.25MShares decreased 42.31%; reported value decreased 12.93%, and weight changed -0.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20250.35%313,660$21.64MShares decreased 51.97%; reported value decreased 51.10%, and weight changed -0.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 12, 2025
Q3 20250.45%383,446$28.91MShares increased 22.25%; reported value increased 33.61%, and weight changed +0.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2025
Q4 20250.36%315,010$25.00MShares decreased 17.85%; reported value decreased 13.52%, and weight changed -0.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20260.35%335,010$24.06MShares increased 6.35%; reported value decreased 3.76%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 13, 2026
Q2 20260.39%288,689$29.86MShares decreased 13.83%; reported value increased 24.12%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 10, 2026
EDMOND DE ROTHSCHILD HOLDING S.A. · CVS HEALTH CORP

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1649647","quarter":"2026Q2","cusip":"126650100"}

get_institutional_manager_history
{"cik":"1649647","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.